The industrialisation of lifesciences poses significant challenges to the industry’s approach of financing and managing of research and development. Great public budget constraints across the world, the need to adopt new protection mechanisms as regards personal data and disruptive new competition from emerging tech companies, force the industry to undergo a profound transformations.

Our vast industry experience and cross-practice approach provides our clients with unparalleled legal advice, from the most significant pharma companies operating in the market to medical device companies, biotechs, investors and financing entities.

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.